Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Bicycle Therapeutics PLC changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 101 | 101 | 0 |
| Shares | 32.4M | 31.4M | −1.03M (−3.2%) |
| Value | $651.3M | $567.4M | −$83.9M (−12.9%) |
New holders (21)
Institutions that held Bicycle Therapeutics PLC at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Westfield Capital Management Co LP | 917,304 | $16.6M | 0.10% |
| Ridgeback Capital Investments L.P. | 844,235 | $15.3M | 62.17% |
| Man Group plc | 174,074 | $3.15M | 0.01% |
| Walleye Capital LLC | 150,126 | $2.71M | 0.04% |
| ADAR1 Capital Management, LLC | 74,825 | $1.35M | 0.61% |
| Walleye Trading LLC | 50,241 | $908.4K | 0.01% |
| Wexford Capital LP | 34,879 | $630.6K | 0.14% |
| Tocqueville Asset Management L.P. | 23,350 | $422.2K | 0.01% |
| HRT Financial LP | 19,913 | $360.0K | 0.00% |
| EntryPoint Capital, LLC | 18,495 | $334.4K | 0.32% |
| L & S Advisors Inc | 10,190 | $184.2K | 0.02% |
| PEAK6 Investments LLC | 9,000 | $162.7K | 0.01% |
| The PNC Financial Services Group, Inc. | 7,560 | $136.7K | 0.00% |
| Leonteq Securities AG | 5,000 | $90.4K | 0.01% |
| Coppell Advisory Solutions LLC | 1,076 | $15.0K | 0.00% |
| GAMMA Investing LLC | 522 | $9.11K | 0.00% |
| Ronald Blue Trust, Inc. | 138 | $3.00K | 0.00% |
| Advisory Services Network, LLC | 115 | $2.08K | 0.00% |
| Arlington Trust Co LLC | 53 | $958 | 0.00% |
| Northwestern Mutual Wealth Management Co | 5 | $90 | 0.00% |
| Arete Wealth Advisors, LLC | 3,772 | – | – |
Sold out (21)
Institutions that held Bicycle Therapeutics PLC at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Braidwell LP | 1,289,872 | $25.9M |
| Janus Henderson Group PLC | 910,930 | $18.3M |
| Sio Capital Management, LLC | 796,933 | $16.0M |
| Deerfield Management Company, L.P. (Series C) | 448,753 | $9.02M |
| AlphaCentric Advisors LLC | 58,500 | $1.18M |
| Ghisallo Capital Management LLC | 50,000 | $1.00M |
| Simplex Trading, LLC | 31,534 | $633.0K |
| Alpha DNA Investment Management LLC | 27,957 | $561.7K |
| AE Wealth Management LLC | 24,773 | $497.7K |
| Mach-1 Financial Group, Inc. | 24,701 | $496.2K |
| Maven Securities LTD | 22,500 | $452.0K |
| Engineers Gate Manager LP | 16,076 | $323.0K |
| Sandia Investment Management LP | 5,000 | $100.5K |
| BIT Capital GmbH | 4,850 | $97.4K |
| Cutler Group LP | 2,400 | $48.0K |
| BluePath Capital Management, LLC | 1,534 | $30.8K |
| Raleigh Capital Management Inc. | 185 | $3.72K |
| Highline Wealth Partners LLC | 110 | $2.21K |
| Newbridge Financial Services Group, Inc. | 40 | $804 |
| Bell Investment Advisors, Inc | 24 | $483 |
| Wells Fargo & Company | 12 | $241 |